Autor:	Edward N. Squire
Rok vydání:	2011
Předmět:	chemistry.chemical_compound Nicotinic agonist chemistry business.industry Anesthesia Absolute risk reduction Medicine Letters General Medicine Varenicline Placebo business
Zdroj:	Canadian Medical Association Journal. 183:1404-1405
ISSN:	1488-2329 0820-3946
DOI:	10.1503/cmaj.111-2070
Popis:	In their sophisticated review and meta-analysis, Singh and colleagues calculated the absolute risk for varenicline as 1.06% and that for placebo at 0.82%.[1][1] Hence, the correct absolute risk elevation (ARE) is the difference between the two percentages (0.24%, or 0.0024), which they also
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbc85eaa74b861e5d6f8ca1d3ce75d4 https://doi.org/10.1503/cmaj.111-2070 Zobrazit plný text záznamu